The use of bisphosphonates is linked to a reduced risk for fragility fractures in patients with polymyalgia rheumatica on ...

Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations We conducted a retrospective ...

Please provide your email address to receive an email when new articles are posted on . A new clinical practice guideline from the Endocrine Society recommends treatment with IV bisphosphonates or ...

Bisphosphonates are prescription drugs that improve bone density. They’re used to treat several conditions associated with bone loss, including osteoporosis, and to reduce the risk of fractures.

NEW YORK (Reuters Health) Jan. 3 A report in the Journal of the American Dental Association for January clarifies the risk of jaw osteonecrosis associated with bisphosphonates. Intravenous ...

Adjunct Faculty, Fay W. Whitney School of Nursing, University of Wyoming, Laramie, Wyoming; Adult and Family Nurse Practitioner and Co-owner, Wright & Associates Family Healthcare, Amherst, New ...

Osteoporosis is underrecognized and undertreated despite the availability of effective therapies that reduce fracture risks. Bisphosphonates are currently the most widely prescribed pharmacologic ...

NEW YORK (Reuters Health) - A report in the Journal of the American Dental Association clarifies the risk of jaw osteonecrosis associated with bisphosphonates, which are used to prevent or slow the ...